Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;57(1):106172.
doi: 10.1016/j.ijantimicag.2020.106172.

Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Luis Gabriel Parra-Lara  1 , Juan José Martinez-Arboleda  2 , Daniel Francisco Isaza-Pierotti  3 , Fernando Rosso  4
Affiliations

Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Luis Gabriel Parra-Lara et al. Int J Antimicrob Agents. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None

Comment in

References

    1. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [Internet] 2020 http://www.ncbi.nlm.nih.gov/pubmed/32205204 Available from. - PMC - PubMed
    1. Lover AA.Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial. 2020;
    1. Rothman KJ, Lash TL, Greenland S. Lippincott Williams and Wilkins; Philadelphia: 2008. Modern Epidemiology.

LinkOut - more resources